Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2)-Reference-Cited by-同舟云学术

Involvement of miR-20a in Promoting Gastric Cancer Progression by Targeting Early Growth Response 2 (EGR2)

Published:2013-08-06 Issue:8 Volume:14 Page:16226-16239
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Li Xiangsheng,Zhang Zhichao,Yu Ming,Li Liqi,Du Guangsheng,Xiao Weidong,Yang Hua

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/14/8/16226/pdf

Reference32 articles.

1. Global cancer statistics;Jemal;CA Cancer J. Clin,2011

2. Progress of research in gastric cancer;Ali;J. Nanosci. Nanotechnol,2012

3. Macro-role of microRNA in gastric cancer;Link;Dig. Dis,2012

4. microRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers;Song;Gastroenterology,2012

5. microRNAs in breast cancer initiation and progression;Liu;Cell. Mol. Life Sci,2012

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LncRNA RUNX1-IT1 is downregulated in gastric cancer and suppresses the maturation of miR-20a by binding to its precursor;HISTOL HISTOPATHOL;2023

2. Expression profiling of signal transducer and activator of transcription3 in oral squamous cell carcinoma in south Indian population;Minerva Dental and Oral Science;2023-10

3. Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progression;Computers in Biology and Medicine;2023-06

4. In silico prediction and experimental validation of MIR17HG long non-coding RNA, MIR17HG-derived miRNAs and GPC5 expression profile in Breast Cancer;2023-05-22

5. MicroRNA signature and integrative omics analyses define prognostic clusters and key pathways driving prognosis in patients with neuroendocrine neoplasms;Molecular Oncology;2023-03-05